You are here: Industry Insights > immunotherapies

News List

Boehringer Ingelheim, Enara Bio sign pact to discover novel shared antigens for cancer immunotherapies expresspharma
January 13, 2021
Boehringer Ingelheim and Enara Bio announced that they have entered into a strategic collaboration and licensing agreement to research and develop novel targeted cancer immunotherapies, leveraging Enara Bio’s Dark Antigen discovery platform.
HCC Therapeutic Regimens Rewritten by Tumor Immunotherapies: the 12 Years from Sorafenib to Tumor Immunotherapies PharmaSources/1℃
March 18, 2020
Opdivo kicked off the era of HCC immunotherapies in the world, and AiRuiKa’s taking the lead in receiving the approval for HCC indication in China was an important milestone!
AZ, Transgene to collaborate on immunotherapies pharmatimes
May 10, 2019
AZ, Transgene to collaborate on immunotherapies
Kineta Enters Research Collaboration and License Agreement with Pfizer americanpharmaceuticalreview
December 18, 2018
Kineta Immuno-Oncology has entered into a strategic research collaboration with Pfizer to develop RIG-I agonist immunotherapies for the treatment of cancer.....
KIO, Pfizer Enter Research Collaboration contractpharma
December 18, 2018
Kineta Immuno-Oncology has entered into a strategic research collaboration with Pfizer Inc. to develop RIG-I agonist immunotherapies for the treatment of cancer.
Immatics, Genmab to develop bispecific cancer immunotherapies biospectrumasia
July 16, 2018
Immatics and Genmab to Combine Proprietary Technologies to Create Transformative Bispecific Therapies against Novel, Proprietary Tumor Targets
Europe's biggest private biotech company raises $270 million biospectrumasia
April 04, 2018
Europe's biggest private biotech company raises $270 million BioNTech has already signed a $310 million deal with Roche
Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis biospace
March 21, 2018
The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A
Explore the Research Progress of Over 2,400 Gene Therapies in the World en-cphi.cn
September 11, 2017
CAR-T and Other Immunotherapies Encounter Obstructions at Their Beginning
Pierre Fabre and H-Immune Announce Strategic Research Partnership to Develop Potentially Ground-Brea americanpharmaceuticalreview
March 23, 2017
Pierre Fabre have entered into a strategic research partnership which will utilize H-Immune’s unique technology platform to generate lead candidates of fully human antibodies to serve as the initial step in a program to develop immuno-oncology therapeutic

Previous page 1 2 Next page